» Articles » PMID: 39340036

Combating the Co-Circulation of SARS-CoV-2 and Seasonal Influenza: Identifying Multi-Dimensional Factors Associated with the Uptake of Seasonal Influenza Vaccine Among a Chinese National Sample

Overview
Date 2024 Sep 28
PMID 39340036
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The co-circulation of COVID-19 and seasonal influenza highlighted the importance of promoting influenza vaccination. However, the influenza vaccination rate among the Chinese population is low and requires further promotion. This study examined multi-dimensional factors, such as knowledge of seasonal influenza, health perceptions, cues to action, patient-provider relationships, and COVID-19 pandemic-related factors, in relation to the uptake of the seasonal influenza vaccine (SIV) among the Chinese population.

Methods: A cross-sectional, self-administered online survey using a quota sampling method was conducted among Chinese adults 18 years and older between June and August 2022. Multivariate logistic regression was performed to explore factors associated with the 2021 SIV behavior.

Results: A total of 3161 individuals from different regions of China were included in this study. The multivariate logistic regression demonstrated that perceived severity of influenza, perceived barriers to taking SIV, cues to action, a stable relationship with providers, worry about contracting COVID-19 in immunization settings, non-pharmaceutical interventions (NPIs), and awareness of the influenza vaccine in protecting against COVID-19 were significantly associated with the SIV uptake.

Conclusions: This study examined multi-dimensional factors that may influence SIV uptake. Health promotion programs should incorporate multi-dimensional factors, including personal and environmental factors, related to SIV promotion during the co-circulation period.

References
1.
Jiang M, Yao X, Li P, Fang Y, Feng L, Hayat K . Impact of video-led educational intervention on uptake of influenza vaccine among the elderly in western China: a community-based randomized controlled trial. BMC Public Health. 2022; 22(1):1128. PMC: 9169441. DOI: 10.1186/s12889-022-13536-8. View

2.
Ferdinands J, Thompson M, Blanton L, Spencer S, Grant L, Fry A . Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research. Vaccine. 2021; 39(28):3678-3695. DOI: 10.1016/j.vaccine.2021.05.011. View

3.
Zhu A, Zheng Y, Qin Y, Liu S, Cui J, Li Z . [A systematic review of the economic burden of influenza in China]. Zhonghua Yu Fang Yi Xue Za Zhi. 2019; 53(10):1043-1048. DOI: 10.3760/cma.j.issn.0253-9624.2019.10.017. View

4.
Jiang X, Shang X, Lin J, Zhao Y, Wang W, Qiu Y . Impacts of free vaccination policy and associated factors on influenza vaccination behavior of the elderly in China: A quasi-experimental study. Vaccine. 2021; 39(5):846-852. DOI: 10.1016/j.vaccine.2020.12.040. View

5.
Grohskopf L, Ferdinands J, Blanton L, Broder K, Loehr J . Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-25 Influenza Season. MMWR Recomm Rep. 2024; 73(5):1-25. PMC: 11501009. DOI: 10.15585/mmwr.rr7305a1. View